HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
1 Year Est. Return
+230.96%
AUM
$362M
AUM Growth
-$26.1M
(-6.7%)
Holding
180
Top Buys
| 1 | +$4.86M | |
| 2 | +$3.76M | |
| 3 | +$3.75M | |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
+$3.21M |
| 5 |
DFTX
Definium Therapeutics
DFTX
|
+$3.15M |
Top Sells
| 1 | +$7.08M | |
| 2 | +$5.16M | |
| 3 | +$5.14M | |
| 4 |
CDTX
Cidara Therapeutics
CDTX
|
+$5.06M |
| 5 |
ACLX
Arcellx
ACLX
|
+$4.89M |
Sector Composition
| 1 | Healthcare | 66.93% |
| 2 | Technology | 9.01% |
| 3 | Industrials | 5.47% |
| 4 | Consumer Discretionary | 2.89% |
| 5 | Financials | 2.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $30.6M | 8.45% |
1,057,238
|
|
||
|
ABVX
2
Abivax
ABVX
$5.78B
| $12.6M | 3.48% |
113,254
+41,069
|
|
||
3
Praxis Precision Medicines
PRAX
$7.19B
| $8.48M | 2.34% |
26,323
+482
|
|
||
4
Cogent Biosciences
COGT
$5.6B
| $7.58M | 2.09% |
197,051
-139,616
|
|
||
5
Spyre Therapeutics
SYRE
$6.01B
| $7.38M | 2.04% |
146,264
-41,942
|
|
||
6
Vaxcyte
PCVX
$6.85B
| $7.24M | 2% |
124,647
+10,598
|
|
||
7
Revolution Medicines
RVMD
$32.2B
| $6.74M | 1.86% |
69,309
-50,931
|
|
||
|
TERN
8
DELISTED
Terns Pharmaceuticals
TERN
| $6.03M | 1.66% |
114,307
-61,155
|
|
||
9
Structure Therapeutics
GPCR
$2.64B
| $5.97M | 1.65% |
123,909
-69,092
|
|
||
10
Nuvalent
NUVL
$7.22B
| $5.8M | 1.6% |
56,602
-16,685
|
|
||
11
Immunovant
IMVT
$6.35B
| $5.59M | 1.54% |
225,139
+3,256
|
|
||
|
SLNO
12
DELISTED
Soleno Therapeutics
SLNO
| $5.53M | 1.53% |
165,227
+30,158
|
|
||
13
Tyra Biosciences
TYRA
$1.7B
| $5.03M | 1.39% |
131,304
+96,218
|
|
||
14
Amylyx Pharmaceuticals
AMLX
$1.48B
| $4.89M | 1.35% |
352,085
+113,273
|
|
||
15
Amazon
AMZN
$2.76T
| $4.66M | 1.29% |
22,397
+5,000
|
|
||
|
LBRX
16
LB Pharmaceuticals
LBRX
$775M
| $4.28M | 1.18% |
173,595
+33,488
|
|
||
17
Relay Therapeutics
RLAY
$3.42B
| $4.2M | 1.16% |
421,881
-123,198
|
|
||
18
Insmed
INSM
$22.5B
| $3.98M | 1.1% |
24,316
-15,084
|
|
||
19
NVIDIA
NVDA
$5.4T
| $3.91M | 1.08% |
22,420
+8,200
|
|
||
|
ORKA
20
Oruka Therapeutics
ORKA
$3.33B
| $3.87M | 1.07% |
+78,911
|
|
||
21
Cytokinetics
CYTK
$9.63B
| $3.87M | 1.07% |
58,643
-55,921
|
|
||
22
Liquidia Corp
LQDA
$4.9B
| $3.76M | 1.04% |
99,744
-56,259
|
|
||
23
Ocular Therapeutix
OCUL
$1.82B
| $3.74M | 1.03% |
441,573
+97,506
|
|
||
24
Tarsus Pharmaceuticals
TARS
$2.47B
| $3.68M | 1.02% |
52,464
-1,100
|
|
||
25
BridgeBio Pharma
BBIO
$12.5B
| $3.68M | 1.02% |
49,560
-30,645
|
|